(Q58286147)

English

Four years of universal pneumococcal conjugate infant vaccination in Germany: Impact on incidence of invasive pneumococcal disease and serotype distribution in children

article

In more languages

Statements

scholarly article

0 references

Four years of universal pneumococcal conjugate infant vaccination in Germany: Impact on incidence of invasive pneumococcal disease and serotype distribution in children (English)

0 references

1 reference

based on heuristic

inferred from title

Mark van der Linden

object named as

Mark van der Linden

1

0 references

Rüdiger von Kries

6

object named as

Rüdiger von Kries

0 references

author name string

Susanne Weiß

2

0 references

Gerhard Falkenhorst

3

0 references

Annette Siedler

4

0 references

Matthias Imöhl

5

0 references

language of work or name

0 references

publication date

August 2012

0 references

number of pages

6

1 reference

based on heuristic

inferred from page(s)

0 references

30

0 references

5880-5885

0 references

40

0 references

Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.068

7 January 2021

Serotype replacement in disease after pneumococcal vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.068

7 January 2021

Early effectiveness of heptavalent conjugate pneumococcal vaccination on invasive pneumococcal disease after the introduction in the Danish Childhood Immunization Programme

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.068

7 January 2021

Indirect effect of conjugate pneumococcal vaccination in a 2+1 dose schedule

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.068

7 January 2021

Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.068

7 January 2021

Pneumococcal meningitis in the era of pneumococcal conjugate vaccine implementation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.068

7 January 2021

Effects of pneumococcal conjugate vaccine 2 years after its introduction, the Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.068

7 January 2021

Invasive pneumococcal disease in Portugal prior to and after the introduction of pneumococcal heptavalent conjugate vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.068

7 January 2021

Reduction in the incidence of invasive pneumococcal disease after general vaccination with 7-valent pneumococcal conjugate vaccine in Germany

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.068

7 January 2021

Effect of pneumococcal conjugate vaccine on pneumococcal meningitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.068

7 January 2021

Streptococcus pneumoniae in western Europe: serotype distribution and incidence in children less than 2 years old.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.068

7 January 2021

Blood culture sampling rates at a German pediatric university hospital and incidence of invasive pneumococcal disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.068

7 January 2021

Proportion of invasive pneumococcal infections in German children preventable by pneumococcal conjugate vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.068

7 January 2021

Childhood invasive pneumococcal disease in Germany between 1997 and 2003: Variability in incidence and serotype distribution in absence of general pneumococcal conjugate vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.068

7 January 2021

Counting birds, bees, and NCDs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.068

7 January 2021

Postlicensure evaluation of the effectiveness of seven valent pneumococcal conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.068

7 January 2021

Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.068

7 January 2021

Efficacy of 7-valent pneumococcal conjugate vaccination in Germany: An analysis using the indirect cohort method

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.068

7 January 2021

Impact of the seven-valent pneumococcal conjugate vaccination (PCV7) programme on childhood hospital admissions for bacterial pneumonia and empyema in England: national time-trends study, 1997-2008.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.068

7 January 2021

Identifiers

10.1016/J.VACCINE.2012.06.068

0 references

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q58286147&oldid=2031073028"